GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Days Payable

Innovative Pharmaceutical Biotech (HKSE:00399) Days Payable : 203.78 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Days Payable?

Innovative Pharmaceutical Biotech's average Accounts Payable for the six months ended in Mar. 2024 was HK$2.69 Mil. Innovative Pharmaceutical Biotech's Cost of Goods Sold for the six months ended in Mar. 2024 was HK$2.41 Mil. Hence, Innovative Pharmaceutical Biotech's Days Payable for the six months ended in Mar. 2024 was 203.78.

The historical rank and industry rank for Innovative Pharmaceutical Biotech's Days Payable or its related term are showing as below:

HKSE:00399' s Days Payable Range Over the Past 10 Years
Min: 48.43   Med: 197.33   Max: 443.11
Current: 184.14

During the past 13 years, Innovative Pharmaceutical Biotech's highest Days Payable was 443.11. The lowest was 48.43. And the median was 197.33.

HKSE:00399's Days Payable is ranked better than
89.36% of 1081 companies
in the Retail - Cyclical industry
Industry Median: 52.75 vs HKSE:00399: 184.14

Innovative Pharmaceutical Biotech's Days Payable declined from Mar. 2023 (312.21) to Mar. 2024 (203.78). It may suggest that Innovative Pharmaceutical Biotech accelerated paying its suppliers.


Innovative Pharmaceutical Biotech Days Payable Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Days Payable Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 443.11 208.29 246.54 307.88 186.37

Innovative Pharmaceutical Biotech Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 395.39 312.21 205.62 203.78 142.17

Competitive Comparison of Innovative Pharmaceutical Biotech's Days Payable

For the Specialty Retail subindustry, Innovative Pharmaceutical Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's Days Payable Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Innovative Pharmaceutical Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Days Payable falls into.



Innovative Pharmaceutical Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Innovative Pharmaceutical Biotech's Days Payable for the fiscal year that ended in Mar. 2024 is calculated as

Days Payable (A: Mar. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2023 ) + Accounts Payable (A: Mar. 2024 )) / count ) / Cost of Goods Sold (A: Mar. 2024 )*Days in Period
=( (4.022 + 1.853) / 2 ) / 5.753*365
=2.9375 / 5.753*365
=186.37

Innovative Pharmaceutical Biotech's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (3.52 + 1.853) / 2 ) / 2.406*365 / 2
=2.6865 / 2.406*365 / 2
=203.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Pharmaceutical Biotech Days Payable Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech Business Description

Traded in Other Exchanges
N/A
Address
145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Executives
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines